DocumentsDate added
Case report:- Conservative Dentistry and Endodontics
Ambica Khetarpal1,Sarika Chaudhary2,Sangeeta Talwar3, Mahesh Verma4& Kirti Chawla5
1Senior Research Associate,2Associate Professor,3Professor and Head, 4Director-principal, 5Senior resident, Department of Conservative Dentistry and Endodontics, Maulana Azad Institute of Dental Sciences,Bahadur Shah Zafar Marg, New Delhi – 110002 Delhi,India.
Abstract:- Management of a mutilated tooth with little or no clinical crown remaining poses a great challenge for the clinician. The successful treatment of such a badly broken tooth with pulpal disease depends not only on good endodontic therapy, but also on good prosthetic reconstruction of the tooth. In such cases, additional retention and support of the restoration are difficult to achieve as this requires non-violation of the biologic width through surgical crown lengthening procedure. The present case report describes the retreatment of a maxillary premolar with post-core restoration. The effectiveness and thoroughness of crown lengthening carried out using a Er,Cr:YSGG laser was highly appreciable. Post-operative patient satisfaction in terms of aesthetics and pain was excellent, proving the efficiency of the procedure in achieving remarkable healing.
Keywords:- Er,Cr:YSGG laser, mutilated tooth, crown lengthening, healing, FRC post.
References:-
1.Silverstein WH. The reinforcement of weakened pulpless teeth. J Prosthet Dent 1964; 14:372–81.
2.Goto Y., Nicholls J., Phillips K. and Junge T. Fatigue resistance of endodontically treated teeth restored with three dowel-and-core systems JPD 2005, 93, (1), 45-50.
3.Bateman G., Ricketts D. N. J. and Saunders W. P. Fiber-based post systems: a review. Br Dent J 2003, 195 (1) 41-8.
4.Plotino G., Grande N. M., Bedini R., Pameijer H. and Somma F. Flexural properties of endodontic posts and human root dentin. Dent Mat 2007; 23, (9)1129-35.
5.Nakamura T., Ohyama T., Waki T., Kinuta S., Wakabayashi K., Mutobe Y., Takano N. and Yatani H. Stress analysis of endodontically treated anterior teeth restored with different types of post material. Dent Mat J 2006 Mar: 25(1): 145-50.
6.Yu DG, Kimura Y, Kinoshita J, Matsumoto K. Morphologic and atomic analytical studies on enamel and dentin irradiated by an ErCr:YSGG laser. J Clin Laser Med Surg. 2000; 18(3): 139-43.
7.Kimura Y, Yu DG, Yamashita A, et al. Effects of ErCr:YSGG laser irradiation on canine mandibular bone. J Periodontol. 2001; 72(9):1178-82.
8.Dederich DN, Bushick RD. Lasers in dentistry separating science from hype. J Am Dent Assoc. 2004; 135(2):204-12.
9.Dean DB. Concepts in laser periodontal therapy: Using the Er,Cr:YSGG laser. The Academy of Dental Therapeutics and Stomotology A Peer-Reviewed Publication, Continuing Education Course, 2005.
10.Jetter C. Soft-tissue management using an Er,Cr:YSGG laser during restorative procedures. Compend Contin Educ Dent. 2008 Jan-Feb; 29(1):46-9.
11.Ishikawa I, Aoki A, Takasaki AA. Clinical application of erbium:YAG laser in periodontology.J Int Acad Periodontol. 2008 Jan; 10(1):22-30.
12.Schalter R. The Er,Cr:YSGG laser in various restorative treatments. J Acad Laser Dent 2005; 13:26-29.
Original article:-
M. D. Dixit1, Kishore Bhat2*, Mohan D. Gan3 & Aruneshwari Dayal3
1Head of the Department & Professor,2Research Officer,3Professor,CVTS,Jawaharlal Nehru Medical College and Karnataka Lingayat Educational Society’s Dr.Prabhakar Kore Hospital & Medical Research Centre, Belgaum, Karnataka, India.
Abstract:- Background and Objectives: Several chronic microbial infections are being considered as newer risk factors for atherosclerosis and CAD. But the reports are conflicting and the published data from India is scarce. An attempt has been made in the present study to evaluate the role of pathogen burden in subjects with and without CAD in a Tertiary Care Hospital in Karnataka,India. Methods: Seropositivity to IgG antibodies specific for Chlamydia pneumoniae, Helicobacter pylori, Herpes simplex virus type 1 and 2 and Cytomegalovirus was investigated in 274 patients with CAD and 275 apparently healthy individuals by ELISA test. The presence of conventional risk factors including hyperlipidemia, hypertension, diabetes, smoking and BMI were recorded. Occurrence of angina and MI also were noted. Results: There was a significant difference in the incidence of CMV, H. pylori and C. pneumoniae between CAD patients and controls, but the association was weak after multivariate analysis. On the other hand, pathogen burden was significantly higher in study group. The presence of risk factors was very high in patients (73.82%) in contrast to controls (11.3%). The association between MI and pathogen burden was statistically significant. Interpretation and conclusion: our data provide strong evidence that pathogen burden may have direct bearing on the incidence of CAD and also on the occurrence of cardiac complications such as MI. On the other hand, the association of individual infections with CAD appears to be weak. More such studies, prospective in nature are needed before definite conclusions can be drawn.
Keywords:- Coronary Artery Disease, H. pylori, C. pneumonia, HSV, CMV, Risk factors, Myocardial infarction & Pathogen burden.
References:-
1.Fong IW. Ed. Infections and the cardiovascular system; New Perspectives, Kluwer Academic Publishers, New York,; 2004:78.
2.Epstein SE, Zhou YF, Jhu J. Infection and atherosclerosis: emerging mechanistic paradigms. anCirculation 1999; 100: 20-28
3.Neito JF. Infections and atherosclerosis. New clues from an old hypothesis? Am J Epedemiol. 1998; 148:937-948.
4.Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hayner G, Prellwitz W et.al., Impact of viral and bacterial infectious burden on ling term prognosis in patients with coronary artery disease. Circulation 2001; 104:25-31.
5.Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000; 163: 49-56.
6.Klein CE, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G et. al., Impact of infectious burden on extent and long term prognosis of atherosclerosis. Circulation 2002; 105: 15-21.
7.Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q et. al., Multiple infections and subsequent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study. Circulation 2003; 107: 251-7.
8.Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000; 20: 1417-20.
9.Muhlestein JB, Anderson JL. Infectious serology and atherosclerosis – how burdensome is the risk? Circulation 2003; 107: 220-2.
10.Stollberger C, Finsterer J. Role of infections and immune factors in coronary and cerebrovascular arteriosclerosis. Clin Vac Immunol 2002; 9: 207-215.
11.Mayr M, Kiechl S, Mendall MA, Willet J, Wick G, Xu Q. Increased risk of atherosclerosis is confined to CagA positive Helicobacter pylori strains. Stroke 2003; 34: 610-15.
12.Pussinen PJ, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontopathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003; 23: 1250-4.
13.Meurman JH, Sanz M, Janket SJ. Oral Health, Atherosclerosis and Cardiovascular disease. Crit Rev Oral Biol Med 2004; 15: 403-13.
14.Desvarieux M, Demmer RT, Rundek T, Boden – Albala B, Jacobs Jr DR, Sacco RL et al,. Periodontal microbiota and carotid intima media thickness: the oral infections and vascular disease epidemiology study (INVEST). Circulation 2005; 111: 576-82.
15.Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circulation Res 2002; 90: 2-4.
16.Perumal V, Mathai E, Jose J, Gupta S. Prevalence of Chlamidia pneumoniae IgG antibodies in patients with coronary artery disease. A report from an Indian population. Indian Heart J 2003; 55: 667.
17.Goyal P, Kale SC, Chaudhary R, Chauhan S, Shah N. Association of common chronic infections with coronary artery disease in patients without any conventional risk factors. Indian J Med Res 2007; 125: 129-36.
18.Choudhary A, Rajasekhar D, Latheef SA, Subramaniyam G. Seropositivity of Chlamidia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in South Indian population. Ind J Pathol Microbiol 2004; 47: 433-4.
19.Jha SC, Prasad J, Mittal A. High Immunoglobulin A seropositivity for combined Chlamidia pneumoniae, Helicobacter pylori infection and high sensitivity C Reactive Protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart and Vessels 2008; 23: 390-6.
20.Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 114-26.
21.Epstein SE, Zhu J, Naafi AH, Burnett MS. Insights in to the role of infection in atherogenesis and plaque rupture. Circulation 2009; 119: 3133-41.
22.Danesh J, Whincup P, Walker M et al. Chlamidia pneumoniae IgG titres and coronary heart disease: prospective study and metaanalysis. BMJ. 2000; 321: 208-13.
23.Danesh J. Coronary artery disease, Helicobacter pylori, dental disease, Chlamidia pneumoniae and Cytomegalovirus: metaanalyses of prospective studies. Am Heart J. 1999; 138: s434-7.
24.Ridker PM, Danesh J, Youngman L, Colliins R, Stampfer MJ, Peto R etal., A prospective study of helicobacter pylori seropositivity and the risk for future myocardial infection among socioeconomic similar US men Ann Intern Med. 2001 Aug 7;135(3):184-8.
25.Neito FJ. Viruses and atherosclerosis: a critical review of the epidemiological evidence. Am Heart J. 1999; 138: s453-60.
26.Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM et al., Effects of total pathogen burden on coronary artery disease risk and C Reactive Protein levels. Am J Cardiol. 2000; 85: 140-6.
27.Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103: 45-51.
Copyright © 2013 Bhat Kishore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Case report:-
Yadava Jeve* , Aisha Janjua & Najum Qureshi
Birmingham Women's NHS Foundation Trust Metchley Park Road, Edgbaston, Birmingham B15 2TG, United Kingdom.
Abstract:- This is case of secondary post-partum hemorrhage due to uterine arterio-venous malformation (AVM) caused after caesarean section. AVM was treated with Rusch Balloon and selective uterine artery embolization.
Keywords:- Arteriovenous malformation; Rusch Balloon; Uterine Artery Embolization.
References:-
1.Diwan RV, Brennan JN, Selim MA, et al. Sonographic diagnosis of arteriovenous malformation of the uterus and pelvis. J Clin Ultrasound. 1983;11:295–8.
2.Forssman L, Lundberg J, Schersten T. Conservative treatment of uterine arteriovenous fistula. Acta Obstet Gynecol Scand 1982;61(1):85–7.
3.Yang JJ, Xiang Y, Wan XR, Yang XY. Diagnosis and management of uterine arteriovenous fistulas with massive vaginal bleeding. Int J Obstet Gynaecol. 2005;89:114–119.
4.Poppe W, Assche FA, Wilms G, Favril A, Baert A. Pregnancy after transcatheter embolization of a uterine arteriovenous malformation. Am J Obstet Gynecol. 1987;156:1179–80.
5.Vaknin Z, Sadeh-Mefpechkin D, Halperin R, Altshuler A, Amir P, Maymon R. Pregnancy-related uterine arteriovenous malformations: experience from a single medical center. Ultraschall Med. 2011 Dec;32 Suppl 2:E92-9. Epub 2011 May 25.
6.Bagga R, Verma P, Aggarwal N, Suri V, Bapuraj JR, Kalra N. Failed Angiographic Embolization in Uterine Arteriovenous Malformation. Medscape J Med 2008;10:12
7.Kelly SM, Belli AM, Campbell S. Arteriovenous malformation of the uterus associated with secondary postpartum Haemorrage. Ultrasound Obstet Gynecol. 2003 Jun; 21(6):602-5.
8.Salazar GM, Petrozza JC, Walker TG Transcatheter endovascular techniques for management of obstetrical and gynecologic emergencies. Tech Vasc Interv Radiol. 2009 Jun; 12(2):139-47.
9.Grivell RM, Reid KM, Mellor A. Uterine arteriovenous malformations: a review of the current literature. Obstet Gynecol Surv. 2005 Nov;60(11):761-7.
10.O'Berien P, Neyastani A, Buckley AR, Chang SD, Legiehn GM. Uterine arteriovenous malformation from diagnosis to treatment. J Ultrasound Med 2006; 25:1387-92.
11.Papadakos N, Wales L, Hayes K, Belli AM, Loftus I, Ray S Post-traumatic pelvic pseudoaneurysm and arterio-venous fistula: combined endovascular and surgical approach Eur J Vasc Endovasc Surg. 2008 Aug;36(2):164-6. Epub 2008 Jun 3.
12.Wang Z, Chen J, Shi H, Zhou K, Sun H, Li X, Pan J, Zhang X, Liu W, Yang N, Jin Z Efficacy and safety of embolization in iatrogenic traumatic uterine vascular malformations. Clin Radiol. 2012 Jun;67(6):541-5. Epub 2012 Jan 18.
Copyright © 2013 Yadava Jeve. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original research article:- Community Medicine
Aditya Suryabhan Berad* & Prabhakar Gangadhar Anwekar.
1Associate Professor, Department of Community Medicine, Mamata Medical College, Khammam, Andhra Pradesh—452016, India.
2Assistant Professor, Department of Community Medicine, Index Medical College, Indore, Madhya Pradesh-452016, India.
Abstract:- Aims and objective of study: To study the co- morbidities in children (0-6 years age) and malnutrition in rural area. Material and methods: The study was carried out in the two adopted villages coming in the field practice area of rural health training center of medical college in Indore district of Madhya Pradesh. Data was collected from 231 children and their mothers regarding socio-demographic profile, immunization, morbidity profile, dietary history and child feeding practices by using predesigned and pretested interview proforma. Anthropometric measurements of child were also done. Results: The proportion of children having stunting (37.66%), wasting (41.12%) and underweight (51.94%), anaemia (58.44%), calorie deficit (60.60%) and incomplete immunization status (35.93%) was found to be high in rural areas of Indore district, Madhya Pradesh, India. Conclusion: More emphasis needs to be given to the child health services in the district particularly rural areas to improve the coverage as well as utilization of the child health services through the primary health care system.
Keywords:- Co-morbidities, Malnutrition, Children.
References:-
1.WHO. UNICEF, UNFPA (2004). Maternal Mortality in 2004. Estimates developed by WHO. UNICEF and UNFPA.
2.Nutrition in India. National Family Health Survey (NFHS-3), India, 2005-06. Mumbai: International Institute for Population Sciences; Calverton, Maryland, USA: ICF Macro.
3.UNICEF (2009). State of World's Children 2009.
4.Jelliffe DB. The assessment of the nutritional status of the community. Geneva: World Health Organisation Monograph series; 1966.
5.Rakesh Kumar, Pradeep R.Deshmukh, Bishan S. Garg. Incidence and correlates of ‘growth faltering among 0-6 y children: A Panel study from Rural Wardha. Indian J Pediatr ( March 2012) 79(3): 333-41.
Original research article:-Pulmonary Medicine
Gupta Ashish K1 ,Mehmood Tariq2 & Khan Mohd H3*.
1 Senior resident, Department of Pulmonary Medicine, Rural institute of medical sciences & research Safai, Etawa U.P, India.
2 Assistant Professor, Department of Pulmonary Medicine, Motilal Nehru Medical College (MLNMC), Allahabad, U.P, India.
3 Assistant Professor, Department of Community Medicine, Rohilkhand Medical College, Bareilly,(U.P), India.
Abstract:- Background: Both inadequate prescription and non-compliance with antituberculosis drugs have resulted in the emergence of a dreadful known as multi drug resistant (MDR) tuberculosis.
Objective:
1.To find out prevalence of antituberculosis drug resistance pattern in suspected case of drug resistant Tuberculosis.
2. To find out predominant patterns of drug resistance and will useful in provides guidance on appropriate regimes for treatment of MDR tuberculosis.
Study design: Hospital based study. Setting: Department of pulmonary medicine, Motilal Nehru Medical College (MLNMC), Allahabad, (U.P) India. Participants: 52 patients. Sampling: Purposive sampling method. Results: Out of 52 patients 23(44.23 %) were relapse, 22(42.30 %) were treatment failure and 7(13.46 %) were defaulter. Single drug Resistance was in 13 (25.49 %) patients. Single drug resistance to isoniazid in 7(13.7%) patient, Ethambutol 5(9.8%) patient and in streptomycin 1(1.96) patient. 10 (19.6%) patients were two drug resistance. The most common two drug combination pattern was isoniazid and ethambutol in 4(7.84%) patients followed by isoniazid and Pyrazinamide in 2(3.92) patients and in 1(1.96%) patients each of HR, RS, ZS and ES. 11 patients were 3 drug resistance. Most common three drug pattern was HZE and HRS 3(5.9%) each. five (9.8%) patients were 4 and >4 drugs resistance. Most common combination was HRZE in 2 (3.92%). Conclusion: There is an urgent need for timely identification of suspect of drug resistance by early referral for culture and drug sensitivity test for prompt initiation of appropriate treatment to improve outcome as well as to sever the chain of transmission.
Keywords:- Single drug resistance, Multi drug resistance, Defaulter, Treatment failure, Relapse.
References:-
1.Surendra K. Sharma, Alladi Mohan. Tuberculosis 1st Edition 2001. Jaypee Brother Medical Publisher (P) Ltd. New Delhi, India
2.Pabloz-Mendez A, Raviglione MC, Laszle A. Binkin N, Rieder HL, Bustreo F. et al. Global surveillance for anti tuberculosis- drug resistance 1994-1997. N Eng J Med. 1998; 338: 1641-9.
3.Espinal M. Multi drug resistant tuberculosis: basis for the development of an evidence based case management strategy for Multi drug resistant tuberculosis within the WHO DOTS strategy. Proceedings of 1998 meeting and protocol recommendations, Geneva WHO 1999.
4.Espinal M. Raviglione M, Kochi A. Rational DOTS plus for the control of Multi drug resistance International J tuberculosis and lung disease 1999; 3: 561-3.
5.Desiree TB D'souza, Nerges F Mistry et al. High level of multi drug resistant tuberculosis in new and treatment failure patients from the revised national tuberculosis control programme in an urban metropolis (Mumbai) in Western India. BMC Public health 2007;10: 1186/1471 2458-9-211.
6.Lt. Col. RB Deoskar et al. Study of drug resistant pulmonary tuberculosis. MJAFI 2005; 61: 245-8.
7.Dam. T, M. Isa, and M. Bose et al. Drug sensitivity profile of clinical mycobacterium tuberculosis isolates-a retrospective study from a chest disease institute India. Journal of Medical microbiology 2005; 54: 269-71.
8.Saha AR, Agarwal SK, Saha KV. Study of drug resistance in previously treated tuberculosis patient in Gujarat, India (2000-2001). International J. of Tuberculosis and Lung disease 2002; 6 (12):1098-1101.
9.Hanif M, Malik S, Dhingra VK (2006). Acquired drug resistance pattern in tuberculosis cases at the state tuberculosis centre, Delhi, India. Int. J. tuber and lung diseases 2009;13(1): 74-8.
10.Anuradha B et al. Prevalence of drug resistance under the DOTS strategy in Hyderabad. South India, 2001-2003. International Journal of tuberculosis and lung disease 2006 Jan, 10(1): 58-62.
11.Javed A. Malik et al. Study of anti mycobacterium drug resistance in pulmonary tuberculosis in Kashmir, India Jr. for the Practicing Doctor 5 ( 4) :2008-09.
12.Janmeja AK. Raj B. Acquired drug resistance in tuberculosis in Haryana. J assoc. Physician India 1998 Feb, 46(2): 194-8.
13.B. Malhotra et al. Drug susceptibility profile of mycobacterium tuberculosis isolates at Jaipur. India Jr. of Medical microbiology. 2002;20 (2): 76-8.
Copyright © 2013 Gupta Ashish K,Mahmood Tariq & Khan Mohd H. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.